MABSPACE BIOSCIENCES
MabSpace Biosciences, is a biotech company focused on discovery and development of innovative antibody based therapeutics for cancer and fibrotic diseases. It was founded in 2013 by indrustrial veterans and is located in Biobay Suzhou, an emerging bitech incubator in China. MabSpace employes its proprietary platform technology, immune tolerance breaking technology (IMBT), to generate lead antibodies with diverse epitopes. MabSpace has established multiple antibody discovery and co-development pa... rtnerships based on this technology. MabSpace raised 15 million USD from Lilly Asia Ventures in 2015 to advance its lead antibody program, a potentially best-in-class anti-PD-L1 antibody with unique pH-dependent binding and recycling property and significantly improved efficacy in animal models. It has also built a panel of 2nd generation immuno-oncology antibodies targeting different components of the tumor microenvironment,which enables the testing of combination therapeutic interventions with its PD-L1 antibody.
MABSPACE BIOSCIENCES
Industry:
Biotechnology Health Diagnostics Medical
Founded:
2011-01-01
Address:
Suzhou, Jiangsu, China
Country:
China
Website Url:
http://www.mabspacebio.com
Total Employee:
51+
Status:
Active
Contact:
0512-67079200
Email Addresses:
[email protected]
Total Funding:
55 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Content Delivery Network Domain Not Resolving Mobile Non Scaleable Content Amazon Baidu Analytics HiChina DNS Adobe Dreamweaver
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Aorui Bio
Aorui Bio is a biotech R&D company that combines whole genome liquid biopsy and ML tech for wireless cancer early screening technology.
BluMaiden Biosciences
BluMaiden Biosciences is a Platform Biotechnology Company discovering microbiome-derived disease therapeutic solutions
Carbios
Carbios is a chemistry company that focuses on discovering and developing enzymatic bioprocesses applied to plastic and textile polymers.
COYOTE
Coyote Bioscience is the developer of point-of-care molecular diagnostics, pathogen detection, and life science tools.
Genocea Biosciences
Genocea Biosciences is a biopharmaceutical company which is engaged in developing novel vaccines and immunotherapies.
iCheck
iCheck is a check the origin of the product or conduct a complete purchase. simple.
JingKe Dx
JingKe Dx is a biotechnology company that focuses on genetic testing services for medical diseases.
MagBioSense
MagBiosense (LLC) is a private medical device company focused on the development of breakthrough diagnostic device & assays
Mosaic
Mosaic is a technology company that provides children's precise development and professional rehabilitation services.
NeuroSense Therapeutics
NeuroSense Therapeutics is a clinical-stage drug development company, advancing a groundbreaking treatment for ALS.
Numab
Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.
OncoStem Diagnostics
OncoStem is a diagnostic oncology company focused on discovering and developing novel tests for improved treatment planning.
Tisenc
Tisenc is engaged in the R&D and production of single-person automatic chemiluminescence analyzer.
Current Employees Featured
Founder
Investors List
Lilly Asia Ventures
Lilly Asia Ventures investment in Series B - MabSpace Biosciences
Sequoia Capital China
Sequoia Capital China investment in Series B - MabSpace Biosciences
King Star Capital
King Star Capital investment in Series B - MabSpace Biosciences
Lilly Asia Ventures
Lilly Asia Ventures investment in Series A - MabSpace Biosciences
Official Site Inspections
http://www.mabspacebio.com
- Host name: ec2-18-163-83-197.ap-east-1.compute.amazonaws.com
- IP address: 18.163.83.197
- Location: Hong Kong
- Latitude: 22.2909
- Longitude: 114.15
- Timezone: Asia/Hong_Kong
More informations about "MabSpace Biosciences"
MabSpace Biosciences - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 0512-67079200 MabSpace Biosciences, is a biotech company focused on discovery and development of innovative antibody based …See details»
MabSpace Biosciences - PitchBook
Developer of antibody based therapeutics designed to treat cancer and fibrotic disorders affecting lung, kidney and liver.See details»
Mabspace Biosciences - Craft
The company employes its proprietary platform technology, immune tolerance breaking technology (IMBT), to generate lead antibodies with diverse epitopes. See insights on …See details»
MabSpace Biosciences - Products, Competitors, Financials, …
MabSpace is headquartered in Suzhou, with a fully-integrated antibody discovery and development facility in Biobay, Suzhou Industrial Park. You're one click away from the most …See details»
MabSpace Biosciences Merged with HJB to Form Transcenta …
Founded in 2013, MabSpace is a clinical stage biotech company focused on discovery, clinical research and commercial development of innovative biologic medicines, particularly in the field …See details»
MabSpace Biosciences Merged with HJB to Form Transcenta …
Founded in 2013, MabSpace is a clinical stage biotech company focused on discovery, clinical research and commercial development of innovative biologic medicines, particularly in the field...See details»
MabSpace Biosciences - Overview, News & Similar companies
Apr 13, 2018 · MabSpace Biosciences contact info: Phone number: +86 51267079200 Website: www.mabspacebio.com What does MabSpace Biosciences do? MabSpace Biosciences Co., …See details»
MabSpace Biosciences Secures $15 Million in Series A Financing …
Nov 2, 2015 · MabSpace Biosciences Co., Ltd. specializes in the discovery and early-development of antibody-based therapeutics, with a focus on developing best-in-class and first …See details»
MabSpace Biosciences merges with bioprocessing technology firm …
Jan 2, 2019 · Hong Kong-based biotech company MabSpace Biosciences has signed a definitive agreement to merge with bioprocessing technologies provider HJB to form a biotherapeutics …See details»
MabSpace Biosciences Secures $15 Million in Series A Financing …
MabSpace Biosciences Co., Ltd., a company focused on the discovery and development of antibody-based therapeutics with proprietary immune tolerance breaking technology, today …See details»
MabSpace Biosciences Announces FDA Approval of IND for …
Feb 22, 2018 · MabSpace plans to start a first-in-human, open label, multiple center, dose escalation and dose expansion study of MSB2311 in patients with locally advanced or …See details»
WuXi Biologics Congratulates MabSpace on FDA Clearance of IND …
Feb 26, 2018 · As part of the collaboration, WuXi Biologics provided comprehensive and integrated services for MSB2311 from cell line development, process, analytical and …See details»
Genor Biopharma, Walvax’s, Partners With Mabspace Biosciences …
May 21, 2015 · MabSpace has an in-licensed fully human antibody transgenic mice platform. MabSpace is headquartered in Hong Kong and has an R&D subsidiary with fully-integrated in …See details»
Ambrx, Inc. And MabSpace Biosciences To Collaborate On Novel …
Jan 5, 2017 · SUZHOU, China--(BUSINESS WIRE)--San Diego based Ambrx Inc. and Suzhou based MabSpace Biosciences have agreed to collaborate on discovery and development of …See details»
HJB Merges with MabSpace Biosciences to Form Transcenta …
HJB and MabSpace Biosciences today announced that the two companies have entered into a definitive merger agreement to create Transcenta Holding Ltd. (Transcenta), a world-class …See details»
MabSpace Biosciences Doses First Patient in China Phase 1 Trial …
Sep 6, 2018 · MabSpace Biosciences Co., Ltd. is a private, venture-backed biotechnology company specialized in discovering and developing innovative antibody therapeutics using its …See details»
MabSpace Initiated Global Phase 1 Trial of MSB2311, Its...
SUZHOU, China--(BUSINESS WIRE)--MabSpace Biosciences announced today that the first subject has been dosed in a Phase 1 clinical study of MSB2311, for the treatment of advanced …See details»
MabSpace Initiated Global Phase 1 Trial of MSB2311, Its 2
Apr 13, 2018 · MSB2311 is a 2 nd Generation PD-L1 antibody with a unique pH-dependent antigen binding property that enables intra-tumor recycling and potentiates tumor penetration. …See details»
MabSpace Biosciences Announces FDA Approval of IND for …
Feb 22, 2018 · SUZHOU, China--(BUSINESS WIRE)-- MabSpace Biosciences announces on February 16th, 2018 FDA cleared Investigational New Drug (IND) for MSB2311, a humanized …See details»
MabSpace Biosciences Doses First Patient in China Phase 1 Trial …
Sep 6, 2018 · SUZHOU, China--(BUSINESS WIRE)-- MabSpace Biosciences announced that on August 24 th, 2018, MSB2311 was successfully administered to the first Chinese cancer …See details»